Literature DB >> 11996390

Canine status epilepticus: a retrospective study of 50 cases.

S R Platt1, M Haag.   

Abstract

The medical records of 50 dogs that exhibited generalised convulsive tonic-clonic (GCTC) status epilepticus (SE) were reviewed and compared with the records of 50 dogs that exhibited non-SE GCTC seizures. The mean age, bodyweight and gender of the patients in both groups were not significantly different. Dogs in the non-SE group were two times more likely to be an idiopathic epileptic than to have secondary epileptic seizures. The SE group was more likely to have abnormalities on cerebrospinal fluid analysis, but not more likely to have abnormalities detected on computed tomography, when compared with the non-SE group. SE was 1.57 times more likely if the cause for the seizures was secondary or reactive epilepsy rather than idiopathic or primary epilepsy. In conclusion, dogs that exhibit SE should be thoroughly investigated for secondary causes.

Entities:  

Mesh:

Year:  2002        PMID: 11996390     DOI: 10.1111/j.1748-5827.2002.tb00047.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  11 in total

1.  A novel implanted device to wirelessly record and analyze continuous intracranial canine EEG.

Authors:  Kathryn A Davis; Beverly K Sturges; Charles H Vite; Vanessa Ruedebusch; Gregory Worrell; Andrew B Gardner; Kent Leyde; W Douglas Sheffield; Brian Litt
Journal:  Epilepsy Res       Date:  2011-06-14       Impact factor: 3.045

2.  Canine status epilepticus: a translational platform for human therapeutic trials.

Authors:  Ilo E Leppik; Edward N Patterson; Lisa D Coles; Elise M Craft; James C Cloyd
Journal:  Epilepsia       Date:  2011-10       Impact factor: 5.864

3.  Canine status epilepticus treated with fosphenytoin: A proof of principle study.

Authors:  Edward E Patterson; Ilo E Leppik; Lisa D Coles; Michael Podell; Charles H Vite; William Bush; James C Cloyd
Journal:  Epilepsia       Date:  2015-05-07       Impact factor: 5.864

4.  Clinical Risk Factors for Early Seizure Recurrence in Dogs Hospitalized for Seizure Evaluation.

Authors:  M Kwiatkowska; A Tipold; E Huenerfauth; A Pomianowski
Journal:  J Vet Intern Med       Date:  2018-02-18       Impact factor: 3.333

5.  Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy.

Authors:  Irene Vuu; Lisa D Coles; Patricia Maglalang; Ilo E Leppik; Greg Worrell; Daniel Crepeau; Usha Mishra; James C Cloyd; Edward E Patterson
Journal:  Front Vet Sci       Date:  2016-12-05

6.  Intranasal Midazolam versus Rectal Diazepam for the Management of Canine Status Epilepticus: A Multicenter Randomized Parallel-Group Clinical Trial.

Authors:  M Charalambous; S F M Bhatti; L Van Ham; S Platt; N D Jeffery; A Tipold; J Siedenburg; H A Volk; D Hasegawa; A Gallucci; G Gandini; M Musteata; E Ives; A E Vanhaesebrouck
Journal:  J Vet Intern Med       Date:  2017-05-24       Impact factor: 3.333

Review 7.  First-line management of canine status epilepticus at home and in hospital-opportunities and limitations of the various administration routes of benzodiazepines.

Authors:  Marios Charalambous; Holger A Volk; Luc Van Ham; Sofie F M Bhatti
Journal:  BMC Vet Res       Date:  2021-03-04       Impact factor: 2.741

8.  Retrospective analysis of seizures associated with feline infectious peritonitis in cats.

Authors:  Doris Timmann; Sigitas Cizinauskas; Ales Tomek; Marcus Doherr; Marc Vandevelde; André Jaggy
Journal:  J Feline Med Surg       Date:  2007-08-31       Impact factor: 2.015

9.  Analysis of Early Assessable Risk Factors for Poor Outcome in Dogs With Cluster Seizures and Status Epilepticus.

Authors:  Giulia Cagnotti; Sara Ferrini; Ugo Ala; Claudio Bellino; Cristiano Corona; Elena Dappiano; Giorgia Di Muro; Barbara Iulini; Ida Pepe; Silvia Roncone; Antonio D'Angelo
Journal:  Front Vet Sci       Date:  2020-10-09

10.  Continuous rate infusion of midazolam as emergent treatment for seizures in dogs.

Authors:  Kathryn Y Bray; Christopher L Mariani; Peter J Early; Karen R Muñana; Natasha J Olby
Journal:  J Vet Intern Med       Date:  2020-12-16       Impact factor: 3.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.